Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule charge-Reference-Cited by-同舟云学术

Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule charge

Published:2014-09-03 Issue:5 Volume:6 Page:1255-1264
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Li Bing,Tesar Devin,Boswell C Andrew,Cahaya Hendry S,Wong Anne,Zhang Jianhuan,Meng Y Gloria,Eigenbrot Charles,Pantua Homer,Diao Jinyu,Kapadia Sharookh B,Deng Rong,Kelley Robert F

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/mabs.29809

Reference26 articles.

1. The Hepatitis C Viruses

2. Identification of novel sequences at the 5′ terminus of the hepatitis C virus genome

3. Replication of hepatitis C virus

4. Overview of Hepatitis C Virus Genome Structure, Polyprotein Processing, and Protein Properties

5. Binding of Hepatitis C Virus to CD81

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coupling cation and anion exchange chromatography for fast separation of monoclonal antibody charge variants;Journal of Chromatography A;2024-09

2. Assessment and incorporation of in vitro correlates to pharmacokinetic outcomes in antibody developability workflows;mAbs;2024-07-31

3. Single-Domain Antibodies—Novel Tools to Study and Treat Allergies;International Journal of Molecular Sciences;2024-07-11

4. Long-Acting Strategies for Antibody Drugs: Structural Modification, Controlling Release, and Changing the Administration Route;European Journal of Drug Metabolism and Pharmacokinetics;2024-04-18

5. Exploring molecular determinants and pharmacokinetic properties of IgG1-scFv bispecific antibodies;mAbs;2024-03-06